1. Home
  2. RVLV vs OGN Comparison

RVLV vs OGN Comparison

Compare RVLV & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$23.29

Market Cap

1.4B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
OGN
Founded
2003
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
RVLV
OGN
Price
$23.29
$13.70
Analyst Decision
Buy
Hold
Analyst Count
12
5
Target Price
$29.73
$11.40
AVG Volume (30 Days)
906.2K
2.6M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
24.64
N/A
EPS
0.46
0.95
Revenue
$1,225,682,000.00
$6,216,000,000.00
Revenue This Year
$10.96
$0.45
Revenue Next Year
$8.01
$1.67
P/E Ratio
$50.30
$14.42
Revenue Growth
8.48
N/A
52 Week Low
$17.35
$5.69
52 Week High
$31.68
$13.72

Technical Indicators

Market Signals
Indicator
RVLV
OGN
Relative Strength Index (RSI) 43.03 71.82
Support Level $21.13 $13.46
Resistance Level $26.97 N/A
Average True Range (ATR) 0.97 0.04
MACD -0.35 0.01
Stochastic Oscillator 7.92 89.47

Price Performance

Historical Comparison
RVLV
OGN

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: